Form 8-K - Current report:
SEC Accession No. 0001477932-23-000597
Filing Date
2023-01-30
Accepted
2023-01-30 08:15:20
Documents
16
Period of Report
2023-01-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K flora_8k.htm   iXBRL 8-K 25213
2 PRESS RELEASE flora_ex991.htm EX-99.1 15868
8 flora_ex991img1.jpg GRAPHIC 1530
  Complete submission text file 0001477932-23-000597.txt   171567

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA flora-20230130.xsd EX-101.SCH 5728
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE flora-20230130_lab.xml EX-101.LAB 14637
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flora-20230130_cal.xml EX-101.CAL 901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flora-20230130_pre.xml EX-101.PRE 9263
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flora-20230130_def.xml EX-101.DEF 2102
10 EXTRACTED XBRL INSTANCE DOCUMENT flora_8k_htm.xml XML 3579
Mailing Address 3406 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312
Business Address 3406 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40397 | Film No.: 23565319
SIC: 2834 Pharmaceutical Preparations